Emails show Amazon colluding with other firms to raise prices, California authorities allege

California Attorney General Rob Bonta alleges Amazon colluded with vendors and rival retailers to raise prices on products including pet treats and Dockers khakis, with examples showing prices rising to $29.99 after coordination with Walmart and Chewy. The filing is part of an antitrust suit launched in 2022, and the trial is scheduled to begin on 19 January 2027. The claims are negative for Amazon sentiment and could pressure the stock on litigation and antitrust risk, though Walmart, Levi’s and Chewy are not defendants.

Analysis

This is less about a near-term earnings hit and more about a structural reset in Amazon’s bargaining power. If regulators can show Amazon effectively coordinated pricing discipline across third-party channels, the strategic damage is that AMZN’s marketplace stops being just a pass-through platform and starts looking like an active price-setter, which raises the probability of remedies that are far more disruptive than a fine: conduct restrictions, monitoring, or forced changes to pricing tools. That would matter most in categories where Amazon’s low-price reputation is the core moat, because even a small perceived reduction in price advantage can shift conversion behavior over months.

The second-order loser is not just AMZN but any retailer whose merchants depend on Amazon traffic or marketplace data to defend pricing. CHWY is structurally exposed because pet is a high-frequency, repeat-purchase category where consumers notice small price deltas and subscribe/auto-ship dynamics amplify price parity; if Amazon can’t coordinate “floor” behavior, CHWY likely regains some pricing freedom but also loses the protection of matched pricing, creating volatility in gross margin optics. WMT is oddly insulated: if the allegation is true, Walmart’s scale and omnichannel price perception let it absorb competitive scrutiny better than AMZN, while any legal overhang on Amazon can redirect value-share to the largest trusted price comparator.

The market is probably still underpricing duration risk. Trial is scheduled years out, but the real catalyst is not verdict timing; it is interim injunctive relief or discovery that broadens the complaint into a wider class of marketplace practices. The bear case on AMZN is that antitrust process increasingly acts like a multiple cap: even if fundamentals stay intact, the probability of a lower long-run take rate and lower advertising/marketplace monetization supports multiple compression before cash flow changes show up.

Contrarian view: the headline may be more damaging for sentiment than for near-term economics. Amazon’s consumer price image is deeply embedded, and the company can argue these were vendor-level interactions rather than centralized cartel behavior; if the court narrows the theory, the stock could recover quickly because the worst-case remedy path is still far away. The key is whether this becomes a broad platform-antitrust case or a narrow pricing dispute; only the former justifies sustained de-rating.

Key Decisions for Investors

• Short AMZN vs long WMT on a 3-6 month horizon: the pair captures legal overhang on AMZN while keeping retail exposure, with WMT benefiting if share migrates to the most trusted low-price banner.
• Buy CHWY downside protection via 6-12 month puts or put spreads: near-term headline risk is elevated, and any loss of Amazon-driven price discipline can compress category margins and raise promo intensity.
• Avoid adding to AMZN until the court’s injunction path is clearer; if holding, hedge with collar structures into the next 1-2 discovery milestones to reduce multiple-risk from additional document releases.
• For event-driven accounts, buy a small AMZN bearish call spread ladder 9-12 months out: the risk/reward improves if the market starts pricing interim remedies before trial, while defined premium limits damage if the case narrows.